key: cord-0768594-anp0n6xr
authors: Antonini, Angelo; Leta, Valentina; Teo, James; Ray Chaudhuri, K.
title: Reply to: “Concerns Raised by Publication of Antonini et al., ‘Outcome of Parkinson Disease Patients Affected by Covid‐19’”
date: 2020-08-11
journal: Mov Disord
DOI: 10.1002/mds.28183
sha: fdc8c1c7c90b9d41b9adcc386b48970747e58f7b
doc_id: 768594
cord_uid: anp0n6xr

nan

A 39% rate of pre-existing multifactorial dyspnea has been described in PD and the symptoms of pneumonia attributed to COVID-19 would therefore be substantially elevated in such patients and more so than a nonsusceptible group. 3 2. Up to 65% of COVID-19 cases may have hyposmia, a common symptom in PD, and there is a possibility that the virus may reach the brainstem, which mediates the cough reflex and breathing, evidence supported by preclinical studies on severe acute respiratory syndrome coronavirus (SARS-CoV) or

Middle East respiratory syndrome coronavirus intranasal inoculation. 4 The cases described in our report were seen by the Parkinson's services led by A.A. and K.R.C. at their respective centers with retrospective data capture, including a full personalized PD assessment. Our cases highlight the key issues of heightened anxiety and increasing levodopa requirement as well as fatigue in COVID-19 PD, as also recently observed in another case series. 5 The deleterious effects of lockdown on PwP, including the lack of exercise and worsening anxiety, are now well documented in several publications and differ from a nonsusceptible population. Our cases also provide insight on the extra care required for PwP on advanced therapies, and publications of relevant case series are important; stroke is now recognized as a neurological complication of COVID-19 following the original case reports of 4 to 6 cases. The object of the case series is to alert, as we have had numerous calls from concerned patients and our case reports have resonated with many PwP and nursing colleagues. Not knowing the consequences of COVID-19 in older self-isolating PwP is a major stressor by itself; therefore, we do not believe that we are causing additional unnecessary stress but, rather, offering reassurance that, armed with practical knowledge, the care of PwP with COVID-19 can be optimal and effective.

Angelo Antonini, PhD, 1 Valentina Leta, MD, 2,3 James Teo, PhD, 2,4 and K. Ray Chaudhuri, DSc 2,3 *

Outcome of Parkinson disease patients affected by Covid-19

Outcome of Parkinson's disease patients affected by Covid-19

Dyspnea: an underestimated symptom in Parkinson's disease

COVID-19 and Parkinson's disease: from bench to bedside

Rapid worsening in Parkinson's disease may hide COVID-19 infection